401(k) · DOL Form 5500 · 2023

Asklepios Biopharmaceutical, Inc. 401(k) Plan

Data updated 2026-08-25

$22M
Total assets Small plan by assets
303
Participants Below avg headcount
74th
Percentile by assets National rank
$72,656
Avg per participant Below avg balance/head
PlainRetire home → About this data RSS: change history

Official DOL plan name: Asklepios Biopharmaceuticals, Inc. 401(k) Plan · Sponsored by Asklepios Biopharmaceutical, Inc. · North Carolina · Professional & Technical Services

$22M in assets, 303 participants

Asklepios Biopharmaceutical, Inc.'s Asklepios Biopharmaceuticals, Inc. 401(k) Plan reported $22M in total assets and 303 participants in its 2023 DOL Form 5500 filing, ranking in the 74th percentile by assets among filed plans. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.

  • #15,121 in Professional & Technical Services (20,321 peers)

Coverage in North Carolina

Asklepios Biopharmaceuticals, Inc. 401(k) Plan covers 303 participants in North Carolina, about 37% of the average North Carolina filer (state average ~819 per filing). Assets: $22M.

#15,121
in Professional & Technical Services (20,321 peers)
+94.0%
assets growth YoY

Asklepios Biopharmaceuticals, Inc. 401(k) Plan's outsized position by total assets

Asklepios Biopharmaceuticals, Inc. 401(k) Plan vs every filed plan by assets

End-of-year total assets · plan year 2023 · DOL Form 5500

$22,014,629 Top 26% higher than 74% of 127,068 filed plans

This plan $0 $2,050,000,000 every filed plan with reported assets, bucketed by value

Dashed line + filled bar = this entry, among filed plans.

Source U.S. Department of Labor Form 5500 filings (EBSA) · plan year 2023

Asklepios Biopharmaceuticals, Inc. 401(k) Plan among mid-size filed plans by headcount

Plan-year 2023 Form 5500 filings with a reported participant count, partitioned by headcount band, not by assets. Asklepios Biopharmaceuticals, Inc. 401(k) Plan sits mid-pack in the medium band (303 participants).

What changed between DOL Form 5500 filings

plan year 2022 → plan year 2023

  • Asklepios Biopharmaceuticals, Inc. 401(k) Plan reported net income rose from $2M in the plan year 2022 filing to $11M in the plan year 2023 filing.
  • Asklepios Biopharmaceuticals, Inc. 401(k) Plan end-of-year assets rose from $11M in the plan year 2022 filing to $22M in the plan year 2023 filing.
  • Asklepios Biopharmaceuticals, Inc. 401(k) Plan reported participants rose from 196 in the plan year 2022 filing to 303 in the plan year 2023 filing.

See the national 2022→2023 release diff →

EBSA filing schedule strip

Filing strip 200267834 · Asklepios Biopharmaceutical, Inc. PY 2023 · 401(k)

Asklepios Biopharmaceuticals, Inc. 401(k) Plan · $22M · 303 · 74th

  • BOY $22M
  • BOY 303
  • BOY 74th
  • BOY 401(k)
  • BOY near Keller Group 401(k) Profit Sharing Plan
  • BOY ind #15121

Stamps derive from this plan's Form 5500 line items (assets, participants, type, EIN, cohort placement) - not a quality rating of the sponsor. Read with Professional & Technical Services retirement plans → · Plans in North Carolina →

Asklepios Biopharmaceuticals, Inc. 401(k) Plan in the asset neighbourhood

Institute of Management Accountants Employees' Retirement PlanInstitute of Management Acco…$22MAsklepios Biopharmaceuticals, Inc. 401(k) PlanAsklepios Biopharmaceuticals…$22MKeller Group 401(k) Profit Sharing PlanKeller Group 401(k) Profit S…$22MStaywell Health Center 401(k) PlanStaywell Health Center 401(k…$22MTrilliant Food & Nutrition 401(k) PlanTrilliant Food & Nutrition 4…$22M
End-of-year total assets ($M) among Asklepios Biopharmaceuticals, Inc. 401(k) Plan and nearest nationwide 401(k) peers. Source: DOL Form 5500 plan year 2023.

North Carolina filing particulars

Total Assets (Beginning of Year)$11M
Net Assets (End of Year)$22M
Net Income$11M
Employer EIN200267834
Plan Effective Date2018-01-01
Filing StatusFILING RECEIVED

Sponsor Plan History (Asklepios Biopharmaceutical, Inc.)

Sponsor-wide plan assets over time

All Asklepios Biopharmaceutical, Inc. plans reported in each filing year

Latest sponsor-wide plan assets
$33M 194.89140769255104% vs 2022
2024 filing year
$0M$10M$20M$30M$40M 202220232024 $11.4M $33.5M ▲ +194.8%
Year Plans Participants Total Assets
2022 1 196 $11M
2023 1 303 $22M
2024 1 394 $33M

Nearby 401(k) Plans in North Carolina

Peer 401(k) plans, same state, same plan type, ranked by total assets.

Asklepios Biopharmaceuticals, Inc. 401(k) Plan vs. nearby 401(k) plans in North Carolina, assets vs. participants Scatter plot of 6 data points. -50000050000100000150000200000 -200204060 Total assets ($B) Participants Asklepios Biopharmaceuticals, Inc. 401(k) Plan, Total assets ($B): 0.022014629 · Participants: 303Asklepios Biopharmaceuticals, Inc. 401(k) PlanThe Bank of America 401(k) Plan, Total assets ($B): 54.848846192 · Participants: 173899The Bank of America 401(k) PlanHoneywell 401(k) Plan, Total assets ($B): 15.388124058 · Participants: 40004Honeywell 401(k) PlanDuke Energy Retirement Savings Plan, Total assets ($B): 10.354065 · Participants: 28121Duke Energy Retirement Savings PlanTruist Financial Corporation 401(k) Savings Plan, Total assets ($B): 10.120701726 · Participants: 55480Truist Financial Corporation 401(k) Savings PlanNucor Corporation Profit Sharing and Retirement Savings Plan, Total assets ($B): 8.510660989 · Participants: 24174Nucor Corporation Profit Sharing and Retirement Savings Plan
Asklepios Biopharmaceuticals, Inc. 401(k) Plan vs. nearby 401(k) plans in North Carolina, assets vs. participants
Compare Asklepios Biopharmaceuticals, Inc. 401(k) Plan side-by-side with 3 peers →

Asklepios Biopharmaceuticals, Inc. 401(k) Plan's out-of-state 401(k) peers by assets and headcount

Outside North Carolina, the nearest 401(k) by assets is Keller Group 401(k) Profit Sharing Plan in TN ($22M); by covered participants it is Emergency Hospital Systems 401(k) Plan in TX (303 participants). Same-state nearby plans are listed separately above.

Similar participant headcount

Nearest other-state filings by covered participants (303 participants); asset peers above are excluded.

DOL Form 5500 plan year 2023. Asset totals can differ widely at the same headcount; neither axis is a quality rating.

Frequently Asked Questions

How did Asklepios Biopharmaceuticals, Inc. 401(k) Plan assets move in 2023? ▼
Asklepios Biopharmaceuticals, Inc. 401(k) Plan surged - up 94.0% during 2023, from $11M to $22M. Reported net income was $11M.
How have Asklepios Biopharmaceutical, Inc. plan assets changed over time? ▼
Across 3 plan years on file (2022-2024), Asklepios Biopharmaceutical, Inc.'s sponsor-wide assets grew 194.9%, from $11M to $33M.
Which 401(k) plans are similar in size to Asklepios Biopharmaceuticals, Inc. 401(k) Plan? ▼
Among 401(k) plans in other states, the closest by assets is Keller Group 401(k) Profit Sharing Plan in TN ($22M, 297 participants).
Which 401(k) plans cover a similar participant headcount to Asklepios Biopharmaceuticals, Inc. 401(k) Plan? ▼
Among 401(k) plans in other states, the closest by covered participants is Emergency Hospital Systems 401(k) Plan in TX (303 participants, $2M in assets).

Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2023.

Source: DOL EFAST2 filing system (efast.dol.gov) - original filing retrieval by EIN 200267834.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from U.S. Department of Labor Form 5500 filings (EBSA). See our methodology for details.